Natera Non-Invasive Prenatal Testing (NIPT)

NIPT uses single nucleotide polymorphism (SNP) technology that requires only a blood draw on the mother. SNP's are the 1% of our DNA that makes us different from one another. This test may be done any time after 10 weeks of pregnancy, but should not be done until after your first appointment with your physician.

Natera Panorama NIPT is a screening for chromosomal abnormalities in the fetus, such as Trisomy 21, 18, 13 and analysis of sex chromosomes, as well as 5 additional microdeletions. It can be used for single and twin pregnancies. Fetal sex can be determined for a single pregnancy and on both fetuses in a twin pregnancy.

If you are interested in having the Natera NIPT testing, or any other genetic testing, you will let your physician know at that first office visit. We are not able to order the testing until you have had your first appointment with your physician.

This test is optional. Natera billing specialists will get a comprehensive view of your insurance and individual situation and help to determine what the cost of testing will be for you. You can learn more at natera.com, by calling 844.778.4700 or by texting "coverage" to 636363. They will discuss with you any out-of-pocket costs in addition to checking your insurance coverage.

Carrier Testing

If you are interested in having Carrier testing, let your physician know at the first office visit.

Carrier testing tells us if a person carries a gene for a disorder. These tests are a screening tool for some commonly inherited disorders. The most common of these are Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA), and Fragile X. Carrier testing screens for the three disorders of Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA) and Fragile X, along with several others. Carrier Testing is a blood test that can be done prior to or during pregnancy.

• Cystic Fibrosis (CF) primarily involves the respiratory, digestive, and reproductive systems. Symptoms may be mild to severe. If the woman tests positive as a carrier, then the father would be tested. If both parents test positive as carriers, there is about a 25% chance of having a child with CF. All newborns in the state of WI are mandated to have a Newborn Screen blood test before discharge from the hospital. This screening includes CF.
  
  
• Spinal Muscular Atrophy (SMA) is a disorder involving the destruction of nerve cells that affect voluntary muscle movement. If the woman tests positive as a carrier, then the father would be tested. If both parents test positive as carriers, there is about a 25% chance of having a child with SMA.
  
  
• Fragile X is a syndrome that mainly involves developmental delay and intellectual disability. If the woman tests positive as a carrier, there is up to a 50% chance of having a child with Fragile X syndrome.

Natera's carrier screening is called Horizon. This test is optional. Natera billing specialists will get a comprehensive view of your insurance and individual situation and help to determine what the cost of testing will be for you. You can learn more at natera.com, by calling 844.778.4700 or by texting "coverage" to 636363. They will discuss with you any out-of-pocket costs in addition to checking your insurance coverage.